Author

C. Sorini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

C. Wu· 1 shared D. Boey· 1 shared E. J. Villablanca· 1 shared G. Nilsson· 1 shared J. Grootens· 1 shared J. S. Dahlin· 1 shared J. S. Ungerstedt· 1 shared M. Ekoff· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. Wu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors

C. Wu, D. Boey, O. Bril, J. Grootens, M. S. Vijayabaskar, C. Sorini, M. Ekoff, N. K. Wilson, J. S. Ungerstedt, G. Nilsson, J. S. Dahlin

Single-cell analysis of human hematopoiesis uncovers the stage at which FcεRI appears during mast cell differentiation and reveals disparate effects of IL-3, IL-5 and IL-33 on mast cell progenitor proliferation, survival, and suppression of FcεRI expression.

bioRxiv · Oct 1, 2021Cell Biology

Conserved transcriptomic profile between mouse and human colitis allows temporal dynamic visualization of IBD-risk genes and unsupervised patient stratification

P. Czarnewski, S. M. Parigi, C. Sorini, O. E. Diaz, S. Das, N. Gagliani, E. J. Villablanca

This study uses cross-species transcriptomic data to identify temporal dynamics of IBD-risk genes and stratify UC patients into two subgroups with distinct therapeutic responses.

bioRxiv · Jan 16, 2019Immunology